Skip to main content

Table 2 Primary and secondary outcomes

From: Nasal high flow therapy in very low birth weight infants with mild respiratory distress syndrome: a single center experience

Outcomes Results
Short-term treatment failure (%)
 Total, n (%) 4 (6.3)
 < 29 week, n (%) 3 (11.5)
 ELBW, n (%) 2 (13.3)
 SGA, n (%) 0 (0.0)
Long-term treatment failure (%)
 Total, n (%) 17 (26.6)
  • Mild BDP 13 (20%)
  • Moderate BDP 3 (4.5%)
  • Severe BDP 1 (1.5%)
 < 29 week, n (%) 14 (53.9)
 ELBW, n (%) 8 (53.3)
 SGA, n (%) 2 (11.1)
Adverse event, morbidity, mortality (%)
 Barotrauma and nasal ulceration, n (%) 0 (0.0)
 Late onset sepsis, n (%) 10 (16.1)
 IVH, n (%) 0 (0.0)
 ROP, n (%) 5 (7.8)
 NEC, n (%) 1 (1.6)
 PDA, n (%) 6 (9.4)
 Exitus, n (%) 0 (0.0)
Duration of HFNCT, mean (DS), h 141.1 (±181.1)
 Median, 72.5
 Min-max 12–720
Maximum flow rates, mean (DS), lpm 7.3 (±0.9)
 Median, 7,5
 Min-max 4,5–10
Maximum FiO2, mean (DS), % 28.1 (±6.5)
 Median, 25,5
 Min-max 21–50
Parenteral nutrition duration, mean (DS), days 13.0 (±9.3)
 Median, 10
 Min-max 2–42
Time to reach full enteral feeding, mean (DS), days 14.6 (±9.4)
 Median, 11
 Min-max 6–49
Time to bottle feed, mean (DS), days 32.1 (±15.0)
 Median, 33
 Min-max 7–85
Length of hospitalization, mean (DS), days 52.4 (±20.0)
 Median, 49
 Min-max 22–94